---
schema_version: "secwatch.filing_event.v1"
accession: "0000078003-26-000085"
form_type: "8-K"
ticker: "PFE"
cik: "0000078003"
company_name: "PFIZER INC"
filed_at: "2026-06-18T11:07:07+00:00"
generated_at: "2026-06-18T11:10:04.798257+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pfizer CFO Dave Denton to step down Aug 15; Cecile Guegan named interim CFO

## Summary
- Dave Denton to step down as CFO effective August 15, 2026, for a consumer goods opportunity.
- Departure not related to Pfizer's financial or operating results or any disagreements.
- Cecile Guegan, SVP Finance, Global Biopharm Business, named interim CFO effective August 16.
- Pfizer will conduct internal and external search for permanent CFO.
- Guegan has over 20 years at Pfizer, led Seagen integration.

## SEC filing metadata
- accession: 0000078003-26-000085
- form_type: 8-K
- ticker: PFE
- cik: 0000078003
- company_name: PFIZER INC
- filed_at: 2026-06-18T11:07:07+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/pfe-20260618.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000078003-26-000085
- JSON: https://secwatch.observer/filing/0000078003-26-000085.json
- Plain text: https://secwatch.observer/filing/0000078003-26-000085.txt

## Key facts
- Executive change
  Cecile Guegan was appointed as Interim Chief Financial Officer at PFIZER INC.
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: the Company announced that Cecile Guegan, the Company’s Senior Vice President, Finance, Global Biopharmaceutical Business, will serve as Interim Chief Financial Officer, effective August 16, 2026
  evidence_url: https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm
- Executive change
  Dave Denton departed as Chief Financial Officer at PFIZER INC.
  - Action: step down
  - Role: Chief Financial Officer
  source text: Dave Denton notified Pfizer Inc. (the “Company”) that he will step down from his current position as Chief Financial Officer effective August 15, 2026
  evidence_url: https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.